Cargando…
Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse
BACKGROUND: Tissue-specific gene deletion has proved informative in the analysis of pain pathways. Advillin has been shown to be a pan-neuronal marker of spinal and cranial sensory ganglia. We generated BAC transgenic mice using the Advillin promoter to drive a tamoxifen-inducible CreERT2 recombinas...
Autores principales: | Lau, Joanne, Minett, Michael S, Zhao, Jing, Dennehy, Ulla, Wang, Fan, Wood, John N, Bogdanov, Yury D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260248/ https://www.ncbi.nlm.nih.gov/pubmed/22188729 http://dx.doi.org/10.1186/1744-8069-7-100 |
Ejemplares similares
-
Tamoxifen-Activated CreERT Impairs Retinal Angiogenesis Independently of Gene Deletion
por: Brash, James T., et al.
Publicado: (2020) -
Generation and characterization of an Advillin-Cre driver mouse line
por: Zurborg, Sandra, et al.
Publicado: (2011) -
Warning regarding hematological toxicity of tamoxifen activated CreERT2 in young Rosa26CreERT2 mice
por: Rossi, Martina, et al.
Publicado: (2023) -
In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control
por: Felker, Anastasia, et al.
Publicado: (2016) -
Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells
por: Tamarina, Natalia A, et al.
Publicado: (2014)